$HRGN
Harvard Apparatus Regenerative Technology Inc

2013 Q4 Form 10-Q Financial Statement

#000114420413064622 Filed on November 27, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $22.00K $0.00 $0.00
YoY Change
Cost Of Revenue $11.00K $0.00 $0.00
YoY Change
Gross Profit $11.00K $0.00 $0.00
YoY Change
Gross Profit Margin 50.0%
Selling, General & Admin $1.580M $1.002M $669.0K
YoY Change 64.58% 49.78%
% of Gross Profit 14363.64%
Research & Development $1.080M $1.058M $1.059M
YoY Change 8.0% -0.09%
% of Gross Profit 9818.18%
Depreciation & Amortization $40.00K $40.00K $40.00K
YoY Change 100.0% 0.0% 300.0%
% of Gross Profit 363.64%
Operating Expenses $2.659M $2.060M $1.728M
YoY Change 35.25% 19.21%
Operating Profit -$2.648M -$2.060M -$1.728M
YoY Change 34.69% 19.21%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$2.648M -$2.060M
YoY Change 34.42%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.648M -$2.060M -$1.728M
YoY Change 34.42% 19.21%
Net Earnings / Revenue -12036.36%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.795M -$5.282M
COMMON SHARES
Basic Shares Outstanding 7.740M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.01M $0.00 $0.00
YoY Change
Cash & Equivalents $14.01M $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $30.00K
YoY Change
Inventory $38.00K $0.00
Prepaid Expenses $421.0K $33.00K
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $14.49M $33.00K $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $575.0K $460.0K $300.0K
YoY Change 31.28% 53.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $575.0K $460.0K $300.0K
YoY Change 31.28% 53.33%
TOTAL ASSETS
Total Short-Term Assets $14.49M $33.00K $0.00
Total Long-Term Assets $575.0K $460.0K $300.0K
Total Assets $15.06M $493.0K $300.0K
YoY Change 3339.27% 64.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $244.0K $126.0K $20.00K
YoY Change 36.31% 530.0%
Accrued Expenses $160.0K $250.0K $130.0K
YoY Change -30.43% 92.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $495.0K $379.0K $160.0K
YoY Change 20.44% 136.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $495.0K $379.0K $160.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $495.0K $379.0K $160.0K
YoY Change 20.44% 136.88%
SHAREHOLDERS EQUITY
Retained Earnings -$1.974M -$18.57M
YoY Change
Common Stock $77.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.57M $110.0K $140.0K
YoY Change
Total Liabilities & Shareholders Equity $15.06M $490.0K $300.0K
YoY Change 3339.27% 63.33%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$2.648M -$2.060M -$1.728M
YoY Change 34.42% 19.21%
Depreciation, Depletion And Amortization $40.00K $40.00K $40.00K
YoY Change 100.0% 0.0% 300.0%
Cash From Operating Activities -$2.090M -$1.770M -$4.370M
YoY Change 36.6% -59.5% 87.55%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$100.0K -$150.0K
YoY Change -6.25% -33.33% 25.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$150.0K -$100.0K -$150.0K
YoY Change -6.25% -33.33% 25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.25M 1.860M 4.520M
YoY Change 861.54% -58.85% 84.49%
NET CHANGE
Cash From Operating Activities -2.090M -1.770M -4.370M
Cash From Investing Activities -150.0K -100.0K -150.0K
Cash From Financing Activities 16.25M 1.860M 4.520M
Net Change In Cash 14.01M -10.00K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.090M -$1.770M -$4.370M
Capital Expenditures -$150.0K -$100.0K -$150.0K
Free Cash Flow -$1.940M -$1.670M -$4.220M
YoY Change 41.61% -60.43% 90.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Assets Current
AssetsCurrent
0 USD
CY2012Q4 us-gaap Assets
Assets
438000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
179000 USD
CY2012Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
232000 USD
dei Trading Symbol
TradingSymbol
HART
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7740026 shares
dei Entity Registrant Name
EntityRegistrantName
Harvard Apparatus Regenerative Technology, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001563665
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
33000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
33000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
460000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
438000 USD
CY2013Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
460000 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
438000 USD
CY2013Q3 us-gaap Assets
Assets
493000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
126000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6169000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4747000 USD
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Depreciation
Depreciation
38000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
126000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
21000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
16000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4747000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18567000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
379000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
411000 USD
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 USD
CY2013Q3 us-gaap Liabilities
Liabilities
379000 USD
CY2013Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
253000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
411000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2060000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-4747000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
974000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
634000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7185000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1058000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1059000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3483000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3025000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10916000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
1728000 USD
us-gaap Operating Expenses
OperatingExpenses
6169000 USD
us-gaap Operating Expenses
OperatingExpenses
4747000 USD
us-gaap Operating Expenses
OperatingExpenses
18567000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18567000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
514000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
349000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1422000 USD
us-gaap Depreciation
Depreciation
123000 USD
us-gaap Depreciation
Depreciation
203000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2060000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1728000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6169000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2060000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-1728000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6169000 USD
CY2013Q3 hart Investment By Parent Company
InvestmentByParentCompany
18681000 USD
CY2012Q4 hart Investment By Parent Company
InvestmentByParentCompany
12425000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18567000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12398000 USD
CY2013Q3 hart Invested Equity Total
InvestedEquityTotal
114000 USD
CY2012Q4 hart Invested Equity Total
InvestedEquityTotal
27000 USD
CY2013Q3 hart Liabilities And Invested Equity
LiabilitiesAndInvestedEquity
493000 USD
CY2012Q4 hart Liabilities And Invested Equity
LiabilitiesAndInvestedEquity
438000 USD
CY2012Q3 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
0 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
0 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28000 USD
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
82000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
91000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
466000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
253000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5597000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
33000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
33000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-53000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4370000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16596000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
146000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
663000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-145000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-146000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-663000 USD
hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
5742000 USD
hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
4516000 USD
hart Proceeds From Investment Made By Parent Company
ProceedsFromInvestmentMadeByParentCompany
17259000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5742000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4516000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17259000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
514000 USD
CY2013Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
700000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1900000 USD
CY2012Q3 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
600000 USD
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1600000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
622340 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
217902 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
49531 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
29972 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
760739 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.07
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.08
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.34
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5720 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5509 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0080 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
220000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
349000 USD
CY2013Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7900000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5000000 USD

Files In Submission

Name View Source Status
0001144204-13-064622-index-headers.html Edgar Link pending
0001144204-13-064622-index.html Edgar Link pending
0001144204-13-064622.txt Edgar Link pending
0001144204-13-064622-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hart-20130930.xml Edgar Link completed
hart-20130930.xsd Edgar Link pending
hart-20130930_cal.xml Edgar Link unprocessable
hart-20130930_def.xml Edgar Link unprocessable
hart-20130930_lab.xml Edgar Link unprocessable
hart-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v361077_10q.htm Edgar Link pending
v361077_ex31-1.htm Edgar Link pending
v361077_ex31-2.htm Edgar Link pending
v361077_ex32-1.htm Edgar Link pending
v361077_ex32-2.htm Edgar Link pending